Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Jan 25, 2023 5:57pm
145 Views
Post# 35246538

RE:RE:RE:RE:RE:enrollment

RE:RE:RE:RE:RE:enrollment

BayStreetWild wrote:

if the company (a company that is unusually "optimistic" and it never works out) that speaks to the FDA... specifically states through its cheif medical officer that it will not end early... You can run stats until the cows come home but.... it's probably not ending early. But you do you and shill what you like. 


mercedesman wrote:

BSW

I'm not the only one. 

I do my research. 


Also consider stats ( I know, prolly not your strong suit) 

if 170 AB >= 10%

if the next 90 AB +/-/> 30% 

Do the math on whether 170+ 90 "confirms" > 10% on 170+ 150  even if the last 60 (of which 20 are control) all die. 


Jus sayin 

MM 


 



yep. I'll do me and you can do you, and the others. 


of course a CMO is always going to say the Trial will go to the end. Not kosher to say otherwise. 

It's up to the FDA and the FDA ONLY.   My guess is that there is a 75% chance they might be persuaded 

just a guess. Don't listen to anonymous posters 

 

<< Previous
Bullboard Posts
Next >>